G

Global Medical Institutes, LLC | Princeton Medical Institute

Research site

(Unclaimed)

Location

256 Bunn Drive, Suite 6, Princeton, New Jersey, United States of America

Site insights

Top conditions

Top treatments

SPN-812

Viloxazine

ABBV-8E12

Bapineuzumab

PCN-101

AF87908

PRC-063

AL002

LY3303560

SUVN-502

Parent organization

This site is a part of Global Medical Institutes, LLC

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 37 total trials

A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease (Autonomy)

The primary purpose of this study is to evaluate the effect of JNJ-63733657 versus placebo on clinical decline as measured by the Integrated Alzheime...

Active, not recruiting

Alzheimer Disease

Cognitive Dysfunction

Drug: JNJ-63733657

Drug: Placebo

Locations recently updated

Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

Efficacy, Safety, and Tolerability of two administrations of COMP360 in participants with treatment-resistant depression (TRD)

Enrolling

Treatment Resistant Depression

Drug: Psilocybin

Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease (TargetTau-1)

The purpose of this study is to assess the effectiveness, safety, and tolerability of BMS-986446 an Anti-MTBR Tau Monoclonal Antibody in participants...

Enrolling

Alzheimer Disease, Early Onset

Other: Placebo

Drug: BMS-986446